Wellgistics Health Introduces HubRx AI: Advancing the AI-Powered Prescription Ecosystem

August 27, 2025 8:00 AM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the introduction of HubRx AI - a fully customizable AI engine built to streamline prescription hub services, reduce costs, and improve patient outcomes.What HubRx AI DeliversHubRx AI is an in-house, full-stack AI agent engine that...

Read more

CBD Life Sciences Inc. (CBDL) Announces Company Will Exhibit at the NECANN Cannabis Conference in Atlantic City, NJ

August 27, 2025 7:00 AM

CBD Life Sciences Inc. (OTC:CBDL), a trailblazer in the CBD and wellness industry, proudly announces that the Company will be exhibiting at the NECANN Cannabis Conference in Atlantic City, New Jersey, on September 5-6, 2025 at the New Jersey Convention Center. CBDL will showcase its flagship brand The CBD Vault at Booth 837, with exhibition hours scheduled for Friday (10AM-5PM) and Saturday (10AM-4PM).Since its inception in 2019, NECANN New...

Read more

The Baker Company Enhances Scientific Engagement and Internal Efficiency With Bioz Badges and a Bioz Content Hub

August 27, 2025 4:00 AM

Bioz, Inc., a cutting-edge AI platform that transforms research citations into powerful marketing and sales resources for companies that sell scientific experimentation tools, is proud to announce a successful partnership with The Baker Company, a global leader in contamination control and lab equipment solutions. Through the integration of Bioz Badges and a Bioz Content Hub, The Baker Company is enhancing the customer experience and arming its...

Read more

Cantargia Granted Important US Patent for Nadunolimab

August 27, 2025 1:50 AM

Cantargia AB (Publ), Nasdaq Stockholm:CANTA, (Cantargia) today announced that the United States Patent and Trademark Office (USPTO) has granted the patent application 17/551,908 directed to the antibody nadunolimab. The patent number is US 12,398,213 and the patent is valid until 2035 (excluding any patent term extension). The granted patent provides protection for method of treatment of Nadunolimab in combination with chemotherapy and/or...

Read more

IRLAB Publishes Interim Report for the Period January - June 2025

August 27, 2025 1:20 AM

IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company's interim report for the period January - June 2025, has been published.KEY HIGHLIGHTS DURING AND AFTER THE SECOND QUARTERIn May, IRLAB was granted another patent that extends the patent protection for the drug candidate mesdopetam in the US.In May, the company reported positive results...

Read more

CV Sciences Launches Ignite: A Men's Performance Formula for Vitality, Recovery, Libido & Focus

August 26, 2025 9:00 PM

CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in proven, science-backed natural ingredients and products, today announced the launch of Ignite, a performance formula designed for men aged 35+ seeking natural support for vitality, recovery, and focus. Ignite combines clinically respected botanicals with full spectrum CBD to help men perform at their best in...

Read more

Where Is The Catholic Marijuana Vote For The Patients?

August 26, 2025 6:00 PM

Nearly fifty organizations - including CatholicVote - have urged President Trump not to reschedule marijuana, citing fear for children and public safety. But where is that same moral urgency when it comes to patients suffering from Huntington's disease and Multiple Sclerosis? Right now, MMJ BioPharma Cultivation has spent seven years battling its own government just to produce FDA-regulated cannabis medicines for clinical trials. Instead of...

Read more

Health Canada Approves MedMira's Reveal(R) Rapid TP Test - Urgent New Tool In The Battle Against Syphilis

August 26, 2025 4:43 PM

MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received approval from Health Canada for its Reveal® TP (Syphilis) Antibody Test (Reveal® TP) - the fastest standalone screening device for syphilis in Canada.A vital point-of-care tool for healthcare professionals, Reveal® TP is a crucial advancement in expanding access to syphilis testing across Canada-particularly in the Prairie provinces, where rates of infectious and congenital...

Read more

Protagonist Therapeutics to Participate in Multiple Investment Bank Conferences in September 2025

August 26, 2025 4:05 PM

Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in multiple investment bank conferences taking place in September.Citi's 2025 Biopharma Back to School Summit; Boston, MA - September 2-3, 2025Format: Fireside ChatDay/Time: Wednesday, September 3 at 9:45 A.M. ETWebcast:...

Read more

Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025

August 26, 2025 4:00 PM

Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing and commercializing RNA delivery technology for targets beyond the liver, today announced that it will host its Half Year 2025 Financial Results and Business Update Call on Friday, August 29, 2025. Founder, Chairman, and CEO Thomas Meyer and COO Covadonga Pañeda will deliver prepared remarks.Event: Altamira Therapeutics First Half 2025...

Read more

PAO Group Inc Acquires Law 90 LLC, Inc. Including its Law 90 Products

August 26, 2025 3:40 PM

PAO Group, Inc. (PAOG:OTC), August 26, 2025, today announced the acquisition of 100% of the membership interest of outstanding shares from Law 90, LLC. Nevada Limited Liability Corporation (the Company). "The Company created "The Legal Helpline" and since 1995 provided exceptional legal representation for Personal Injury, Medical Malpractice, Family Law, Criminal Defence, Probate/Wills and Corp/Contract Law; ensuring that all rights are...

Read more

Europe's Hospital IT Leaders in Germany, France, and Italy Warn: EHDS Push Outpaces Cyber Defenses

August 26, 2025 12:15 PM

Cybersecurity has overtaken other digital priorities as the most acute operational risk to European hospitals, according to a new Black Book™ European survey of 352 hospital IT leaders in Germany (158), France (84), and Italy (110). Respondents describe a widening attack surface driven by ransomware pressure, middleware/API weaknesses, and deferred EHR patching. just as the European Health Data Space (EHDS) enters its transition phase toward...

Read more

Veterinary Referral Center of Central Oregon Strengthens Specialty Care With Board-Certified Anesthesiologist

August 26, 2025 12:00 PM

The Veterinary Referral Center of Central Oregon, a trusted leader in advanced veterinary medicine, is proud to announce the addition of a board-certified veterinary anesthesiologist in September 2025. Dr. Lily Davis, DVM, CVA, DACVAA, will be joining the VRCCO organization, currently based out of Bend, Oregon.Veterinary anesthesiologists are specially trained veterinarians who focus on the administration of anesthesia, pain management, and...

Read more

Action Behavior Centers Expands ABC Academy With Eight New Locations to Support School-Age Children with Autism

August 26, 2025 10:55 AM

ABC Academy is an intentionally designed therapy model for children ages 5-12. It was created to bridge the gap between early intervention and school by providing ongoing support for children who are enrolled in school part-time or full-time. Since its launch, ABC Academy has grown rapidly to meet the needs of families across the Southwest. Today, seven Academy centers operate in Dallas, Houston, San Antonio, Austin, and Phoenix. By the end of...

Read more

LifeRx.md Expands Clinical Services to Include NAD+ and Methylene Blue; Confirms Leadership in GLP and GIP Metabolic Care

August 26, 2025 10:35 AM

LifeRx.md today announced a definitive expansion of its clinical services. After establishing a permanent leadership position in GLP and GIP metabolic care, LifeRx.md will introduce clinician-supervised NAD+ and methylene blue therapies to its treatment menu, effective September 2025. This expansion is a permanent enhancement to LifeRx.md's clinician-led platform. The new therapies will be delivered only after patients complete a medical...

Read more

BetterWay Blood Testing Expands Menu with Iron Panel, Cortisol, Quantitative hCG Pregnancy Test

August 26, 2025 10:15 AM

BetterWay™ blood testing by Babson Diagnostics today announced the addition of six important offerings to its menu: an Iron Panel (consisting of four tests), Cortisol, and Quantitative hCG Pregnancy. With these additions, BetterWay now offers 67 commonly ordered tests, continuing its mission to provide affordable, accessible, and reliable blood testing.The expanded menu brings unique value to patients. The new Quantitative hCG Pregnancy test-the...

Read more

Curiteva Launches the Inspire Anterior Lumbar Portfolio

August 26, 2025 10:00 AM

Curiteva, Inc., a leading technology and manufacturing company, proudly announces the release of the first offering from its innovative Anterior Lumbar Inspire Portfolio. This advanced platform includes implant offerings in both monolithic and stand-alone designs, complemented by a comprehensive plating system for construct support.The Inspire portfolio builds upon its proven success, with more than 7,300 Inspire Interbodies already implanted...

Read more

Michael Jordan's Game-Worn Sneakers Headline 'The Grail Collection' at Infinite Auctions (OTC Pink:MDCE)

August 26, 2025 9:30 AM

Infinite Auctions, a subsidiary of Medical Care Technologies Inc. (OTC PINK:MDCE), is proud to announce the "The Grail Collection," available exclusively at www.infiniteauctions.com. This highly anticipated auction showcases five pairs of Michael Jordan game-worn sneakers, each tied to different defining moments in Jordan's legendary career. Each pair is accompanied by full authentication documentation, making them cornerstone pieces for...

Read more

National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced

August 26, 2025 8:30 AM

Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced that Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel has earned the National Psoriasis Foundation (NPF) Seal of...

Read more

DrHouse Launches Florida's First Telehealth Service With Free On-Demand Prescription Delivery

August 26, 2025 8:30 AM

Floridians can now access care and medication faster than ever. DrHouse, a leading U.S. telehealth app, has introduced its free on-demand prescription delivery service across Florida, including Miami, Tampa, Orlando, Jacksonville, Ft. Myers, Naples, and surrounding areas.With DrHouse, medications arrive right after the virtual visit, typically at the patient's door in about an hour. Unlike other telehealth services with prescription deliveries...

Read more